mdgroup Launches Third Fully Compliant Medical Distribution Centre in Amsterdam
mdgroup, a leading global MedTech and patient health services company pioneering a patient-first approach to clinical research, has today opened its latest medical distribution centre in Amsterdam. One of three hubs worldwide, mdgroup’ s Horreum distribution centre, named after the Latin horrea or storage warehouses, provides sponsors across Europe with clinical trial supply procurement, storage, logistics, and delivery. Horreum integrates seamlessly with mdgroup’s range of specialist clinical services, including mobilehealth home health services and seacolehealth healthcare professional recruitment. This integrated approach to hybrid and decentralised clinical trials (DCT) conduct significantly reduces administrative burden on sites and sponsors, while protecting data quality, participant safety, and regulatory compliance.
One of the biggest challenges facing sponsors hoping to embrace the benefits of hybrid and DCTs is managing logistics and distribution. The model relies on having the right people with the right equipment in the right place at the right time. Failure on any of these elements threatens data quality, patient safety, and regulatory compliance.
Horreum provides an integrated, carefully project-managed approach to home health and distribution. mdgroup specialist teams link the dots between stakeholders by bringing study-critical elements in-house to secure the critical clinical supply chain management. This is supported and integrated seamlessly with mdgroup’s seacolehealth and mobileheath, which ensures specialist teams are on the ground with everything they need to do their job, at the time they need it.
Tarquin Scadding-Hunt, mdgroup CEO, said: “Horreum ensures seamless service and guarantees logistical support between patients, home health, sites, equipment suppliers, central laboratories, and couriers. It connects the entire logistical network, removing the safety, data quality, and compliance challenges that can exist between providers, and eradicating the huge administrative burden on sponsors. For example, when the protocol calls for a patient welcome pack to be printed and delivered before day one, and a blood pressure reading to be taken on day five, mdgroup can deliver on all fronts, from a single brief. We work with couriers who are well versed in the rules and regulations of clinical trials and are dedicated to our mission of crating remarkable experiences for our patients. When there’s a last-minute change of plan, open communication channels within our departments allow us to adapt quickly.”
Companies In This Post
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more